Moderna Inc
(MRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 241,000 | 167,000 | 2,811,000 | 1,831,000 | 344,000 |
| Cost of Goods | 115,000 | 96,000 | 929,000 | 2,241,000 | 731,000 |
| Gross Profit | 126,000 | 71,000 | 1,882,000 | -410,000 | -387,000 |
| Operating Expenses | 1,489,000 | 1,337,000 | 1,876,000 | 1,602,000 | 1,480,000 |
| Operating Income | -1,363,000 | -1,266,000 | 6,000 | -2,012,000 | -1,867,000 |
| Other Income | 84,000 | 101,000 | 64,000 | 54,000 | 118,000 |
| Pre-tax Income | -1,279,000 | -1,165,000 | 70,000 | -1,958,000 | -1,749,000 |
| Income Tax | N/A | 10,000 | -147,000 | 1,672,000 | -369,000 |
| Net Income Continuous | -1,279,000 | -1,175,000 | 217,000 | -3,630,000 | -1,380,000 |
| Net Income | $-1,279,000 | $-1,175,000 | $217,000 | $-3,630,000 | $-1,380,000 |
| EPS Basic Total Ops | -3.33 | -3.07 | 0.62 | -9.53 | -3.62 |
| EPS Basic Continuous Ops | -3.33 | -3.08 | 0.60 | -9.53 | -3.62 |
| EPS Diluted Total Ops | -3.33 | -3.07 | 0.63 | -9.53 | -3.62 |
| EPS Diluted Continuous Ops | -3.33 | -3.08 | 0.61 | -9.53 | -3.62 |
| EPS Diluted Before Non-Recurring Items | -3.33 | -3.07 | 0.55 | N/A | N/A |
| EBITDA(a) | $-1,350,000 | $-1,257,000 | $188,000 | $-1,775,000 | $-1,787,000 |